Clinical usefulness of the ImmunoCyt™ urinary test in the follow-up protocol of patients with urothelial neoplasms;Utilidad clínica del test urinario ImmunoCyt™ en el protocolo de revisiones de pacientes con antecedentes de neoplasia uroteliales

Actas Urologicas Espanolas

Volumn 29, Issue 6, 2005, Pages 535-541

  Garcia Penalver C ^a,b   Perez Barrios A ^a   Leiva Galvis, O ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b NONE   (Spain)

Author keywords

Bladder cancer; Cystoscopy; Urinary cytology

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER TUMOR; CYTOLOGY; FEMALE; HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE; URINALYSIS; URINE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINARY BLADDER NEOPLASMS; URINE;

EID: 26044466153     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-4806(05)73293-9     Document Type: Article

References (13)

1. Denholin SW, Conn IG, Newsam JE et al. Morbidity following cystoscopy: comparison of flexible and rigid techniques. Br J Urol 1990;66:152.
2. Westenfelder M, Rosset K and Pelz Y. Development of nosocomial and iatrogenic urinary tract infections (UTI) following urological interventions. A prospective clinical study. Scand J Nephrol, Suppl 1987;104:59.
3. Olsson H, Zackrisson B. Immnunocyt a useful method in the follow-up protocol for Urol patients with urinary bladder carcinoma. Scand J Urol Nephrol 2001;35(4):280-282.
4. Pode D, Shapiro A, Wald M et al. Noninvasive detection of bladder cancer with the BTA stat test. J Urol 1999;161:443-446.
5. Saad A, Hanbury DC, McNicholas TA et al. The early detection and diagnosis of bladder cancer: a critical review of the options. Eur Urol 2001;39:619.
6. Kausch I, Böhle A. Bladder cancer II. Molecular aspects and dignosis. Eur Urol 2001;39(5):498-506.
7. Chopin DK, Gattegno B. Superficial bladder tumors. Eur Urol 2002;42(6):533-541.
8. Vriesema JL, Atsma F, Kiemeney LA et al. Diagnostic efficacy of the Immnunocyt test to detect superficial bladder cancer recurrence. Urology 2001;58(3):367-371.
9. Pfister C, Chautard D, Devonec M et al. Immnunocyt test improves the diagnostic accuracy of urinary cytology: Results of a Frech multicenter study. J Urol 2003;169(3):921-924.
10. Fradet Y, Lockhart C. Performances characteristics of a new monoclonal antibody test for bladder cancer: Immnunocyt. Canad J Urol 1997;4:400-405.
11. Mian C, Pycha A, Wiener H et al. Immnunocyt a new tool for detecting transitional cell cancer of the urinary tract. J Urol 1999;161:1486-1489.
12. Fradet Y. Recent advances in the management of superficial bladder tumors. The Canadian Journal of Urology 2002;9(3):1544-1544.
13. Nam RK, Redelmeier DA, Spiess PE et al. Comparison of molecular and convencional strategies for followup of superficial bladder cancer using decision analysis. J Urol 2000;163:752-757.